Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis.

Feline mammary carcinoma is highly malignant and generally associated with a poor prognosis, although studies suggest the range of survival times in affected cats is broad. Histologic grading of these tumors is achieved using the Elston and Ellis system, originally developed for human breast cancer. In cats, however, classification using this method has variable prognostic value. Therefore, objectives of this study were (1) to evaluate the Elston and Ellis grading system for feline mammary carcinoma in a predominantly spayed population and (2) to determine whether modification of this system or development of a novel system improved the prognostic value of histologic grading. Survey data and histologic features for 108 carcinomas from 97 cats were analyzed with respect to overall survival. Elston and Ellis grading failed to correlate significantly with overall survival. Using multivariable analysis, lymphovascular invasion, nuclear form, and mitotic count each demonstrated independent prognostic significance (P = .008, <.001, and .004, respectively). Modifications of the Elston and Ellis system and a novel grading system were proposed based on these results; all showed significant correlation with overall survival (P < .001). Median survival times were 27, 29, or 31 months for grade I; 14, 12, or 14 months for grade II; and 13, 5, or 8 months for grade III carcinomas using the mitotic-modified Elston and Ellis, the revised Elston and Ellis, or the novel grading system, respectively. Based on this retrospective study, adoption of the species-specific systems as proposed here may improve the prognostic value of histologic grading for feline mammary carcinoma.

Associations between paratuberculosis milk ELISA result, milk production, and breed in Canadian dairy cows.

The 3 objectives of this study were (1) to quantify milk production differences among cows with different paratuberculosis (ParaTB) milk ELISA results; (2) to determine if production differences existed in lactations preceding the test among cows with different ParaTB milk ELISA results; and (3) to assess whether Channel Island breeds were more likely to test positive with the ParaTB milk ELISA than other dairy breeds. Current and completed lactation records from 35,591 dairy cows in Ontario and western Canada that had been tested with a commercial ParaTB milk ELISA were included in the analysis. The first occurrence of the highest categorical test result was used to classify the cow. Cows were then grouped by the lactation in which the first high-positive (HTP), low-positive, or negative milk ELISA occurred, and comparisons were made within lactation groups. High test-positive cows were defined as those that had an optical density ≥ 1.0 on at least 1 ParaTB milk ELISA. The associations between ParaTB milk ELISA status and milk production, as measured by the 305-d milk yield, were assessed with a series of linear mixed models. The effect of breed on the likelihood of testing positive with the milk ELISA was assessed using a logistic mixed model for the lactation in which the first negative or positive ParaTB milk ELISA occurred. Test-positive cows produced on average 2.9 to 6.8% less milk than negative herdmates in the lactation in which they were tested. The HTP cows produced on average 466, 514, and 598 kg less milk than low-positive herdmates in lactations 1, 2, and 4, respectively. Cows testing low-positive in their second lactation had, on average, a 218-kg higher milk yield in their first lactation than their test-negative herdmates. Otherwise, no association was found between test result and milk production in preceding lactations. Differences in milk production among negative, test-positive, and HTP cows increased with increasing parity. Cows of the Channel Island breeds had 1.4 to 8.3 times the odds to test positive compared with other dairy breeds. The findings of this study are consistent with previous studies that have reported that milk production is lower in test-positive animals. The differences in milk production increased with increasing ELISA optical density scores and parity in which the animal tested positive. However, with the exception of second-lactation cows, no differences in milk production were observed in tests preceding lactations. The differences in milk ELISA status among dairy breeds support the need for further studies investigating the genetic component of ParaTB susceptibility.

Changes in management practices and apparent prevalence on Canadian dairy farms participating in a voluntary risk assessment-based Johne's disease control program.

The objectives of this study were (1) to describe the change in Mycobacterium avium ssp. paratuberculosis (MAP) antibody milk ELISA-positive prevalence in Canadian dairy herds that participated in a risk assessment (RA)-based Johne's disease (JD) control program; (2) to describe the distribution of so-called high-risk management practices on Canadian dairy farms; and (3) to assess if compliance with selected recommendations translated into changes in the scores of associated RA questions. In Ontario and western Canada, 226 herds voluntarily participated in a RA-based JD control program for several years. In 2005-2007, a previsit survey, RA, and MAP-antibody milk ELISA of the entire milking herd were conducted. Therefore, the interpretation of the results of this study is strictly for the MAP-antibody milk ELISA status of cows or herds, because no culture of MAP (of fecal or environmental samples) was conducted due to economic restrictions. In early 2008, a telephone interview was used to determine compliance with recommended management changes after the first RA. In 2008-2009, a second RA and another whole-herd MAP antibody milk ELISA were performed. At both herd tests, about 35% of the farms had at least one MAP-antibody milk ELISA-positive cow, classifying them as a MAP-antibody milk ELISA-positive herd. However, 28.8% of herds had changed their MAP-antibody milk ELISA status between the 2 tests, demonstrating that a single herd test was insufficient to determine the long-term MAP-antibody ELISA status of a herd. The average within-herd MAP-antibody milk ELISA-positive prevalence changed from 5.4 to 4.2% over the study period, but management practices did not change much throughout the 2- to 3-yr period and were similar to those reported in other parts of North America. The overall RA scores decreased at the second RA, in particular for management practices in the calving and preweaned calf area, and when herds were test-positive at the first test. This was not surprising, because many of the recommendations at the first RA focused on these management areas and compliance with some recommended farm-specific management practices in this area might be linked to reduced scores for associated RA questions. In conclusion, the participating farms did, on average, decrease their within-herd MAP-antibody milk ELISA positive-prevalence and RA total scores. Changes in RA scores could be linked to improved management practices, indicating that the RA questions appropriately reflected management practices. Some herds changed their MAP-antibody milk ELISA status between tests, which underlines that a current test of the entire milking herd is necessary to determine the present MAP-antibody milk ELISA status of a dairy herd.

Attitudes of Canadian dairy farmers toward a voluntary Johne's disease control program.

The success of Johne's disease (JD) control programs based on risk assessment (RA) depends on producers' compliance with suggested management practices. One objective of this study was to describe the perception of participating Canadian dairy farmers of the impact of JD, the RA process, and suggested management strategies. The second objective was to describe the cost of changes in management practices following the RA. A telephone survey was conducted with 238 dairy farmers in Ontario, Manitoba, Saskatchewan, Alberta, and British Columbia. The producers agreed to participate in this follow-up study after they had been enrolled in an RA-based voluntary JD control program and had tested their herd with the JD milk ELISA test in 2005 to 2007. The majority of farms had no JD test-positive cows and, although some producers thought they had experienced the economic impact of JD, many did not see JD as a current problem for their herd. The majority of producers enrolled in this program because they were concerned that Mycobacterium avium ssp. paratuberculosis could be perceived by consumers as a cause for Crohn's disease in humans, which could lead to altered purchasing behavior of milk and milk products. Fifty-two farm-specific recommendations had been made after the initial RA. Although the producers generally liked the program and found the recommendations reasonable and feasible, on average only 2 of 6 suggestions made specifically to them were implemented. The recommendation with the highest compliance was culling of JD test-positive cows. The main reasons for noncompliance were that the dairy producer did not believe a change of management practices was necessary or the available barn setting or space did not allow the change. Producers were generally uncomfortable estimating time and monetary expenses for management changes, but found that several suggested management practices actually saved time and money. In addition, 39% of the producers that implemented at least 1 recommendation thought their calf and herd health had improved subsequently. This indicates that the communication of associated benefits needs to be improved to increase the compliance of producers with recommended management practices.

Effect of dietary energy substrate and days on feed on apparent total tract digestibility, ruminal short-chain fatty acid absorption, acetate and glucose clearance, and insulin responsiveness in finishing feedlot cattle.

The objective of this study was to determine the effect of dietary energy substrate and days on feed on apparent total tract digestibility, ruminal fermentation, short-chain fatty acid (SCFA) absorption, plasma glucose and acetate clearance rates, and insulin responsiveness. Eight ruminally cannulated, crossbred growing heifers were randomly allocated to 1 of 2 dietary treatments. The control (CON) diet consisted of 75.2% barley grain, 9.8% canola meal, 9% mineral and vitamin supplement, and 6% barley silage (DM basis). To evaluate the effect of energy source, a high-lipid, high-fiber byproduct pellet (HLHFP) was included in the diet by replacing 55% of the barley grain and 100% of canola meal. The study consisted of 4 consecutive 40-d periods (P1 to P4), with data and sample collection occurring in the last 12 d of each period. Dry matter intake tended ( = 0.10) to decrease by period and HLHFP-fed heifers tended to eat less ( = 0.09). The ADG of the CON was greater than that of the HLHFP during P1 and P4 (treatment × period, = 0.02). Heifers fed HLHFP tended to have greater mean ruminal pH (6.10 vs. 5.96; = 0.07) than heifers fed the CON, but pH was not affected by period. The CON heifers had a greater digestibility for DM, OM, CP, and NDF ( ≤ 0.03), and the digestibility for DM and OM linearly increased ( = 0.01) and for CP, NDF, and starch quadratically increased ( ≤ 0.04) with advancing period. Total SCFA concentration in the rumen was greater ( < 0.01) for the CON than for the HLHFP (141.6 vs. 128.1 m). The molar proportion of acetate and isobutyrate linearly increased and butyrate and valerate linearly decreased ( ≤ 0.05) with advancing periods. The rate of valerate absorption tended to increase (linear, = 0.06) and the ruminal liquid passage rate tended to decrease (linear, = 0.08) with advancing period. The arterial clearance rate of acetate tended to quadratically increase ( = 0.06) with period, whereas the clearance rate of glucose was not affected by treatment or period. Both fasting plasma insulin and the area under the insulin curve in response to glucose infusion linearly increased ( = 0.04) with period. These data suggest that partially replacing barley grain with HLHFP negatively affects total tract digestibility and performance. Moreover, with advancing days on feed, digestibility and insulin resistance increases without changes in ruminal pH and plasma metabolite clearance rates.

Defining risk for low reticuloruminal pH during the diet transition period in a commercial feedlot in western Canada.

The objective of the current study was to measure reticuloruminal pH in cattle in a commercial feedlot setting to determine the incidence and extent of low reticuloruminal pH for steers and heifers as they transition to a high-concentrate finishing diet. Reticuloruminal pH was measured in 16 "mixed breed" steers (4 steers/pen with 4 pens) and 16 "mixed breed" heifers (4 heifers/pen with 4 pens) housed in commercial feedlot pens, with 227 ± 13 and 249 ± 6 cattle/pen cohort steers and heifers, respectively, for the diet transition period. Cattle were transitioned from a diet of 53.5% forage and 46.5% concentrate to a diet of 9.5% forage and 90.5% concentrate on a DM basis using a 40-d transition with 5 dietary steps with the diets containing 41.4, 44.8, 49.8, 52.5, 55.1, and 64.0% nonfibrous carbohydrate. In addition, wheat replaced barley as the grain source during the dietary transition. Reticuloruminal pH was measured using orally administered pH measurement devices that were retrieved at slaughter. Data were analyzed using a mixed model including the fixed effects of sex, diet, and the 2-way interaction to evaluate the effect of diet and sex and with the fixed effects of sex, diet, and day relative to each dietary change along with the 2- and 3-way interactions to evaluate temporal responses as a result of diet change. A repeated measures statement was included for the effect of day. Both the mean and minimum reticuloruminal pH values decreased as the proportion of concentrate in the diet increased ( < 0.001). The area and duration that pH was <5.6 increased with greater inclusion of concentrate in the diet ( < 0.001). The number of cattle experiencing low reticuloruminal pH, defined as pH < 5.6 for >180 min, increased with increasing concentrate, and by the end of the 40-d dietary transition, 83% of the cattle had experienced at least 1 bout of low reticuloruminal pH, with most experiencing between 1 and 3 bouts/diet. These data are interpreted to suggest that cattle are at high risk for experiencing low reticuloruminal pH during the dietary transition but that the extent of low reticuloruminal pH is mild. Moreover, the data suggest that the risk for low reticuloruminal pH increases with increasing proportion of concentrate in the diet. The results also suggest that susceptibility to low reticuloruminal pH may differ between steers and heifers.

Interaction of vitamin A supplementation level with ADH1C genotype on intramuscular fat in beef steers.

Previously, the single nucleotide polymorphism in alcohol dehydrogenase (ADH1C c.-64T>C) was shown to have an association with intramuscular fat (IMF) in the longissimus thoracis (LT) muscle when vitamin A was limited in finishing rations of beef steers. The purpose of this study was to determine the optimum vitamin A supplementation level, in combination with ADH1C genotype, to increase IMF of the LT muscle. In total, 45 TT genotype, 45 CT and 27 CC Black Angus crossbred steers were backgrounded on a commercial ration containing 3360 IU vitamin A/kg dry matter (DM). During finishing, the steers were randomly assigned to one of three vitamin A treatments at 25%, 50% and 75% of the National Research Council recommendation of 2200 IU/kg DM. Treatments were administered via an oral bolus. Carcass quality was evaluated and a sample from the LT muscle was collected for analysis of IMF. A treatment×genotype interaction (P=0.04) was observed for IMF; TT steers on the 75% treatment had higher IMF relative to CT and CC steers on the same treatment. Western blot analysis showed that TT steers had higher (P=0.02) ADH1C protein expression in hepatic tissue. Previously, TT steers exhibited increased IMF when fed limited vitamin A. In the current study, the lack of variation in IMF between treatments and genotypes at the lower vitamin A treatment levels was likely due to the majority of the steers grading Canada AAA (USDA Choice). However, the western blot data supports that TT steers are expected to have higher IMF deposition, due to an increased production of ADH1C. The interaction between ADH1C genotype and vitamin A supplementation level has the potential for use in marker-assisted management programs to target niche markets based on increased marbling.

Effect of repeated through-and-through joint lavage on serum amyloid A in synovial fluid from healthy horses.

The objective of this study was to evaluate the effect of through-and-through joint lavage on systemic and synovial serum amyloid A (SAA), total protein, nucleated cell count and percentage of neutrophils in the synovial fluid of six healthy horses. A prospective experimental study was performed where one healthy tarsocrural joint of each horse was randomly assigned to receive repeated through-and-through joint lavage at 0, 48 and 96 h. Synovial fluid and blood samples were collected at 0 (baseline), 24, 48, 72, 96 and 120 h. Systemic and synovial SAA, total protein, nucleated cell count and percentage of neutrophils were measured and compared to baseline. Concentrations of systemic and synovial SAA percentage of neutrophils were not increased from baseline in contrast to total protein and nucleated cell counts (except for nucleated cell count at 96 h). In conclusion, repeated through-and-through joint lavage did not affect synovial SAA concentrations in horses; however, synovial total protein and nucleated cell count values increased. Some of the total protein and nucleated cell count values observed in this study were within the range reported for septic arthritis 24 h after joint lavage. Hence, synovial SAA may be a valuable marker to evaluate the clinical progression of septic joints after through-and-through joint lavage. Clinical studies evaluating synovial fluid SAA concentrations while treating synovial sepsis with through-and-through joint lavage are warranted.

Giant Mycobacterium fortuitum abscess associated with systemic lupus erythematosus.

A 36-year-old woman with a 1 1/2-year history of systemic lupus erythematosus was first seen in October 1984 with a six-month history of several ulcerated and scarred lesions on the lower extremities. A biopsy specimen showed a granulomatous infiltrate of deep dermis and subcutaneous tissue. Over the next three weeks, the patient developed a violaceous, warm, indurated, tender, fluctuant lesion involving most of the left buttock. A culture showed a rapidly growing atypical acid-fast bacteria, which was later identified as Mycobacterium fortuitum. The patient was treated with surgical drainage of the left hip abscess, followed by a three-week treatment with doxycycline hyclate and amikacin sulfate. She was discharged while receiving oral doxycycline and ethambutol hydrochloride.

Persistent subepidermal blistering in split-thickness skin graft sites. Ultrastructural and antigenic features simulating dystrophic or immunofluorescence-negative acquired epidermolysis bullosa.

We describe a child who began developing subepidermal blisters in the recipient sites of split-thickness skin grafts; this process has continued for almost a year and continues to spare nongrafted skin. Routine histologic and immunofluorescence mapping studies demonstrated this disorder to be a relatively noninflammatory one characterized by sub-lamina densa blister formation. Results of direct immunofluorescence were negative. By electron microscopy, anchoring fibrils were sparse in number and in some areas appeared malformed; otherwise, the basement membrane zone was morphologically unremarkable. Bullous pemphigoid antigen, laminin, type IV collagen, epidermolysis bullosa acquisita antigen, and LDA-1 were all normally expressed along the dermoepidermal junction. In contrast, KF-1 antigen was absent. These findings suggest a disease process confined to skin graft recipient sites with features identical to those previously described with recessive dystrophic or immunofluorescence-negative acquired epidermolysis bullosa.